The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer-Reference-Cited by-同舟云学术

The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer

Published:2020-01-22 Issue:8 Volume:146 Page:2296-2304
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Vangangelt Kiki M.H.¹^ORCID,Green Andrew R.²,Heemskerk Isabelle M.F.¹,Cohen Danielle³,Pelt Gabi W.¹^ORCID,Sobral‐Leite Marcelo⁴,Schmidt Marjanka K.⁴,Putter Hein⁵,Rakha Emad A.²,Tollenaar Rob A.E.M.¹,Mesker Wilma E.¹

Affiliation:

1. Department of SurgeryLeiden University Medical Center Leiden The Netherlands

2. Nottingham Breast Cancer Research Center, Division of Cancer and Stem Cells, School of MedicineThe University of Nottingham, Nottingham City Hospital Nottingham United Kingdom

3. Department of PathologyLeiden University Medical Center Leiden The Netherlands

4. Division of Molecular PathologyNetherlands Cancer Institute Amsterdam The Netherlands

5. Department of Biomedical Data SciencesLeiden University Medical Center Leiden The Netherlands

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32857

Reference41 articles.

1. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018

2. Targeting the Tumor Stroma as a Novel Treatment Strategy for Breast Cancer